Benzinga | May 5, 2021 04:15PM EDT

Ocular Therapeutix Q1 EPS $(0.24) Misses $(0.21) Estimate, Sales $7.34M Miss $7.64M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 41.46 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $7.34 million which missed the analyst consensus estimate of $7.64 million by 3.90 percent. This is a 181.41 percent increase over sales of $2.61 million the same period last year.